Imatinib Completed Phase 2 Trials for Asthma Bronchial Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01097694Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)